Gamida Cell announced today the successful results of the Phase I/II study of its second pipeline product NiCord, umbilical cord derived stem cells expanded using the company's proprietary NAM technology.
http://www.freshnews.com/news/761110/gamida-cell-s-nicord-demonstrates-successful-engraftment-patients-hematological-maligna
http://www.freshnews.com/news/761110/gamida-cell-s-nicord-demonstrates-successful-engraftment-patients-hematological-maligna
No comments:
Post a Comment